Eko announced today that the FDA has issued the company an emergency use authorization (EUA) for its novel ECG-based algorithm designed to provide an easily accessible, rapid screening test for low ejection fraction (low EF), a weak heart pump. Awarded an FDA breakthrough device designation in December 2019, the algorithm’s regulatory review has been further […]
Eko AFib and heart murmur algorithms win FDA clearance
Eko announced today that it won FDA clearance for its suite of algorithms that combine with the company’s digital stethoscopes to screen for heart conditions during routine physical exams. The San Francisco-based company develops an artificial intelligence-powered, cloud-based software application designed to analyze electrocardiogram (ECG) and heart sound/phonocardiogram (PCG) data, using signal processing and convolutional […]
Eko raises $20m Series B for smart cardiac monitor | Funding Roundup, September 26, 2019
Eko said yesterday that it raised a $20 million Series B round for the smart cardiac monitor it’s developing. The San Francisco-based company is working on machine learning technology for a combined digital stethoscope and electrocardiogram, designed for both clinical and at-home monitoring. Eko said more than 3,000 hospitals worldwide use its platform, treating millions […]
Cardiac monitor dev Eko raises $5m in Series A
Cardiac device developer Eko said yesterday it raised $5 million in a Series A round to help support its platform designed for valvular heart disease screening and heart failure monitoring. The round was led by Artis Ventures and joined by Strategic Partners, DreamIt Ventures, 1812 Ventures and Founder.org, the San Francisco-based company said. “Eko and […]
